Sign up
Healthed-White-on-Blue

Neurology

shutterstock_2307935835
A/Prof Craig Beall
Clinical Articles iconClinical Articles

Ten ways diabetes and dementia are linked

New research shows how blood sugar problems affect brain health and vice versa. Here are ten evidence-based insights into how the two conditions are related.

Expert/s: A/Prof Craig Beall, Natasha MacDonald
1896308773
Prof James Vickers
Podcasts iconPodcasts

Midlife interventions that shape brain health

In today’s episode, Prof James Vickers explores the evidence, challenges and opportunities for reducing dementia risk through midlife interventions.

Expert/s: Prof James Vickers
Epilepsy,Seizure.,Man,With,Overdose,Failure.,Medical,Health
Prof Terence O'Brien
Podcasts iconPodcasts

SUDEP – What is it and how to reduce the risk

Prof Terence O'Brien explains what SUDEP is and whether epilepsy-related premature death can be prevented.

Expert/s: Prof Terence O'Brien
Shutterstock_2322533325
Prof Tony Attwood
Podcasts iconPodcasts

Women and autism

Prof Tony Attwood discusses how autism in women can be recognised and diagnosed.

Expert/s: Prof Tony Attwood
shutterstock_1145070659
Lynnette Hoffman
Clinical Articles iconClinical Articles

Assessing fitness to drive for seizures and epilepsy

Driving a car is so crucial to employment, socialisation, and self-esteem that people with epilepsy list it as one of their main concerns, ahead of seizures and even sudden death.

Expert/s: Lynnette Hoffman
1723725679
Scientia Prof Kaarin Anstey
Podcasts iconPodcasts

Dementia risk reduction: The GP’s midlife window – Part 1

In today’s podcast, Scientia Prof Kaarin Anstey explains how midlife offers GPs a unique opportunity to identify and address modifiable dementia risk factors.

Expert/s: Scientia Prof Kaarin Anstey
Close-up,Mri,Of,The,Brain,,The,Doctor,Studies,And,Analyzes
Scientia Prof Henry Brodaty AO
Podcasts iconPodcasts

Donanemab – A GP guide to anti-amyloid therapies

Scientia Professor Henry Brodaty AO explains the evidence for the effectiveness of Donanemab in slowing cognitive and functional decline.

Expert/s: Scientia Prof Henry Brodaty AO
Senior,With,Dementia,Or,Alzheimer's,Is,Comforted,By,Caring,Female
Lynnette Hoffman
Clinical Articles iconClinical Articles

Donanemab approved for early Alzheimer’s disease, but are we ready?

Early identification and referral will be crucial for eligible patients, but access likely an issue…

Expert/s: Lynnette Hoffman
anti- seizure 2
Dr Moksh Sethi
Podcasts iconPodcasts

Optimising anti-seizure medication management: Key considerations for primary care

In today's podcast, Dr Moksh Sethi emphasises targeted monitoring, awareness of medication interactions, and proactive reproductive counselling in the management of anti-seizure medications.

Expert/s: Dr Moksh Sethi
shutterstock_2084522077
Rahul Sidhu
Clinical Articles iconClinical Articles

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Participants with genetic mutations but no cognitive issues at the start of treatment were significantly less likely to develop symptoms...

Expert/s: Rahul Sidhu
shutterstock_2437313741
Fiona Clark
Clinical Articles iconClinical Articles

Can MHT prevent dementia?

Social media influencers are advocating prophylactic use of MHT for cognition, but what does the evidence say…

Expert/s: Fiona Clark
Stethoscope,And,Colored,Paper,With,The,Word,Autoimmune,Disease.,Concept
Dr Fiona Chan
Podcasts iconPodcasts

Multiple sclerosis vs antibody disease – What GPs need to know

Dr Fiona Chan explains that, research has now identified new antibody-mediated demyelinating diseases that have been mistaken for MS in the past.

Expert/s: Dr Fiona Chan

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform